CovalX will be attending The 22nd Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, which will congregate over 1,300 drug discovery professionals in Sheraton, Boston, MA, on September 30- October 3, 2024. Our team will be at Booth #316, please let us know if you are planning to attend the event.
Discovery on Target is a premier event dedicated to the latest advancements in drug discovery and target validation. Held annually, this conference brings together experts, researchers, and industry leaders to discuss cutting-edge technologies, innovative research, and emerging trends in the field. Attendees can expect a comprehensive program featuring keynote presentations, interactive sessions, and networking opportunities designed to foster collaboration and knowledge sharing. Discovery on Target is an essential gathering for professionals seeking to stay at the forefront of drug discovery and therapeutic development.
Mark your calendars and make sure to visit our booth. We look forward to meeting you and exploring how we can support your research goals. Engage with our scientific team, including Ryan Wenzel, to gain valuable knowledge that can revolutionize your research and answer any of your questions regarding epitope mapping and other unique biotherapeutic services. Contact us at infona@covalx.com, +1(617) 297 2263, or CovalX.com
